• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) ONYX; AGENT, INJECTABLE, EMBOLIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) ONYX; AGENT, INJECTABLE, EMBOLIC Back to Search Results
Model Number UNK-NV-ONYX
Device Problem Entrapment of Device (1212)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/01/2003
Event Type  Injury  
Manufacturer Narrative
Citation: endovascular treatment of intracranial arterio-venous malformations with onyx embolization: preliminary experience.Florio f1, lauriola w, nardella m et.Al the device will not be returned for evaluation as it was consumed in the event; therefore, no definitive conclusion can be drawn regarding the clinical observation.Additional information has been requested from the author of this article regarding this case.Should it become available a supplemental report will be submitted.Per onyx instruction for use: do not allow more than 1 cm of onyx¿ les to reflux back over catheter tip.Angioarchitecture, vasospasm, excessive onyx reflux, or prolonged injection time may result in difficult catheter removal and catheter entrapment.Excessive force to remove an entrapped catheter may cause serious intracranial hemorrhage.The long term effects of an entrapped catheter that is left in a patient is unknown, but could potentially include clot formation, infection or catheter migration.Mdrs related to this event: 2029214-2017-00350 2029214-2017-00351 2029214-2017-00352 2029214-2017-00353 2029214-2017-00354 2029214-2017-00355.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information during literature review that during embolization procedure with onyx, three catheters glued at the injection site.In all three cases the treatment was discontinuation due to continuous and massive reflux of onyx into the afferent artery peduncle.Ten patients were treated (7 men, 3 women; mean age: 29 years, range: 12-48 years) for a total of 37 embolizations, 22 with onyx and 15 with acrylic resin.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONYX
Type of Device
AGENT, INJECTABLE, EMBOLIC
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9498373700
MDR Report Key6455708
MDR Text Key71575617
Report Number2029214-2017-00353
Device Sequence Number1
Product Code MFE
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P030004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 03/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNK-NV-ONYX
Device Lot NumberNOT REPORTED
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/13/2017
Initial Date FDA Received04/03/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-